Cyclacel announces closing of $15.2 million underwritten public offering
Cyclacel announced the closing of an underwritten public offering of units for gross proceeds of $15.2 million, which includes the full exercise of the underwriter's over-allotment option to purchase additional shares and warrant. Existing and new investors participated in the offering. July 21, 2017